Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis
OLP Admin
In new research published in The FASEB Journal, Dr. Sîrbulescu’s lab demonstrated the remarkable protective effect of B cells in the context of ALS in a murine model and observed decreased inflammation in a patient with the disease. Previous work by the group showed that the direct application of purified B cells, which are immune […] The post Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis appeared first on Vaccine & Immunotherapy Center .